Search

Your search keyword '"Makishima H"' showing total 471 results

Search Constraints

Start Over You searched for: Author "Makishima H" Remove constraint Author: "Makishima H"
471 results on '"Makishima H"'

Search Results

6. Topic: AS04-MDS Biology and Pathogenesis/AS04a-Normal, MDS, and leukemic stem cells: DER(1;7)(Q10;P10) DEFINES A DISTINCT SUBTYPE OF MYELODYSPLASIA

7. POST-AZACITIDINE CLONE SIZE PREDICTS LONG-TERM OUTCOME OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND RELATED MYELOID NEOPLASMS

8. CTX-712, A NOVEL SPLICING INHIBITOR TARGETING MYELOID NEOPLASMS

9. DISTINCT PATHOGENESIS OF CLONAL HEMATOPOIESIS REVEALED BY SINGLE-CELL MULTI-OMICS SEQUENCING

11. Genomic determinants of chronic myelomonocytic leukemia

12. Germ line DDX41 mutations define a unique subtype of myeloid neoplasms.

13. P037 - Topic: AS04-MDS Biology and Pathogenesis/AS04a-Normal, MDS, and leukemic stem cells: DER(1;7)(Q10;P10) DEFINES A DISTINCT SUBTYPE OF MYELODYSPLASIA

14. O11 - POST-AZACITIDINE CLONE SIZE PREDICTS LONG-TERM OUTCOME OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND RELATED MYELOID NEOPLASMS

20. Somatic PHF6 mutations in 1760 cases with various myeloid neoplasms

22. GFI1 as a novel prognostic and therapeutic factor for AML/MDS

26. P741: DDX41 MUTATIONS DEFINE A UNIQUE SUBTYPE OF MYELOID NEOPLASMS.

27. P466: AMPLIFIED EPOR/JAK2 GENES DEFINE A UNIQUE SUBTYPE OF ACUTE ERYTHROID LEUKEMIA

28. P744: UNBALANCED TRANSLOCATION DER(1;7)(Q10;P10) AS A DISTINCT SUBTYPE IN MYELODYSPLASTIC SYNDROMES

31. Hippocampal Sparing Radiotherapy in adults with Primary Brain Tumors: A comparative planning and dosimetric study using IMPT, IMRT and 3DCRT

34. O09 - Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution: MYELOID NEOPLASMS WITH GERMLINE AND SOMATIC DDX41 MUTATIONS

35. O07 - Topic: AS04-MDS Biology and Pathogenesis/AS04a-Normal, MDS, and leukemic stem cells: COMBINED LANDSCAPE OF SINGLE-NUCLEOTIDE VARIANTS AND COPY-NUMBER ALTERATIONS IN CLONAL HEMATOPOIESIS: ANALYSIS IN 11 234 JAPANESE INDIVIDUALS

37. 943P Long-term outcome of the oldest-old patients (85 years or older) underwent proton beam therapy for hepatocellular carcinoma

38. Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution

39. Topic: AS04-MDS Biology and Pathogenesis/AS04a-Normal, MDS, and leukemic stem cells

Catalog

Books, media, physical & digital resources